Physician profile
Michael Zachareas
NPI 1528000254
$26,870.38
in general payments reported to CMS, 2019-2025
49 companies · $5,824 in 2025
The $5,824 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,673 · 2020: $3,074 · 2021: $3,705 · 2022: $5,296 · 2023: $2,703 · 2024: $2,596 · 2025: $5,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,879 · Consulting Fee: $2,173 · Education: $71.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,878.72 |
| Consulting Fee | $2,172.50 |
| Education | $71.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,414.32 | 2021-2025 | Interstim, Altaviva |
| Ferring Pharmaceuticals INC. | $2,896.41 | 2024-2025 | Adstiladrin |
| Axonics, INC. | $2,850.85 | 2020-2024 | Axonics, Bulkamid |
| Teleflex LLC | $2,341.69 | 2021-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $2,053.92 | 2019-2025 | Myrbetriq, Xtandi |
| Neotract INC. | $1,849.45 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $1,297.18 | 2019-2024 | Aveed, Xiaflex |
| Antares Pharma, INC. | $1,250.81 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Janssen Biotech, INC. | $1,217.99 | 2019-2025 | Erleada, Akeega |
| Urogen Pharma, INC. | $680.69 | 2020-2025 | |
| Coloplast Corp | $510.42 | 2019-2025 | Speedicath |
| Abbvie INC. | $466.90 | 2019-2025 | Botox, Lupron Depot |
| Medtronic USA, INC. | $463.20 | 2019-2020 | |
| Endo USA, INC. | $416.85 | 2024-2025 | Xiaflex, Aveed |
| Alnylam Pharmaceuticals INC. | $413.67 | 2021-2025 | Givlaari |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $395.54 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $365.60 | 2019-2022 | |
| Calyxo, INC. | $326.95 | 2025 | Cvac Aspiration System |
| Dendreon Pharmaceuticals LLC | $294.74 | 2019-2025 | Provenge |
| Laborie Medical Technologies Corp. | $282.46 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Sumitomo Pharma America, INC. | $258.15 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $242.40 | 2019-2020 | |
| Blue Earth Diagnostics | $224.44 | 2019-2022 | |
| Aytu Biopharma, INC. | $224.10 | 2019-2020 | |
| Tolmar, INC. | $221.72 | 2023-2025 | Jatenzo, Eligard |
| Myriad Genetic Laboratories, INC. | $213.55 | 2021-2025 | Prolaris, Myrisk |
| Acerus Pharmaceuticals Corporation | $201.87 | 2020-2022 | |
| Accord Healthcare, INC. | $163.43 | 2022 | |
| Boston Scientific Corporation | $152.07 | 2024 | Ams 700 |
| 180 Medical, INC. | $126.26 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $98.30 | 2023-2025 | Pylarify |
| Halozyme INC | $93.30 | 2023 | |
| Myovant Sciences INC. | $88.21 | 2021-2022 | |
| Urovant Sciences INC | $76.44 | 2021-2022 | |
| Valencia Technologies Corporation | $75.83 | 2025 | Ecoin Device Kit |
| Olympus America INC. | $75.24 | 2025 | Itind System |
| Hollister Incorporated | $74.37 | 2021-2024 | Vapro Plus Pocket |
| Merck Sharp & Dohme LLC | $68.00 | 2020-2025 | Keytruda, Lynparza |
| Amgen INC. | $65.55 | 2019-2020 | |
| Abc Home Medical Supply, INC. | $57.70 | 2024 | |
| Karl Storz Lithotripsy-America | $53.18 | 2019 | |
| Procept Biorobotics Corporation | $35.69 | 2024 | Aquabeam System |
| Kowa Pharmaceuticals America, INC. | $35.59 | 2022 | |
| Immunitybio, INC. | $31.24 | 2025 | |
| Bluewind Medical | $27.39 | 2024 | Revi |
| Astrazeneca Pharmaceuticals LP | $27.26 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.99 | 2022 | |
| Tempus Ai, INC | $23.17 | 2024 | Xt Cdx |
| Sun Pharmaceutical Industries INC. | $21.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Zachareas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.